Their research demonstrated that emodin significantly reduced renal damage by modulating inflammatory pathways, particularly through the regulation of TNF-α (tumor necrosis factor-alpha) and ICAM-1 (intercellular adhesion molecule-1), both of which are key players in the inflammatory response and tissue damage in SLE. Here, TNF is linked to systemic lupus erythematosus.